Varian, A Siemens Healthineers Company
Clinical trials sponsored by Varian, A Siemens Healthineers Company, explained in plain language.
-
Precision proton beams target tumors in new device trial
Disease control CompletedThis trial tested a new proton therapy machine called the Varian ProBeam System. It involved 47 patients with various solid tumors to see how well the machine controlled their cancer and how safe it was. The main goal was to collect data to support the device's approval for medic…
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Advanced proton therapy tested on multiple cancer types
Disease control CompletedThis study tested a new proton therapy system for treating various solid tumors in 47 patients. The goal was to evaluate how well the system controls tumors and how safe it is for patients. Researchers followed patients for 3 months after treatment to measure tumor response and t…
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
New tech aims to make brain tumor radiation safer and simpler
Disease control CompletedThis study collected information on a new, streamlined radiation technique called HyperArc, used to treat brain tumors and cancer that has spread to the brain. It aimed to see how well this method works and how it compares to other treatments. The registry included nearly 1,000 a…
Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
New scanner aims for sharper cancer treatment images
Knowledge-focused CompletedThis study tested a new type of CT scanner used during radiation therapy to see if it could produce clearer images. It involved 41 adults receiving radiation for cancers in areas like the head, neck, lung, breast, abdomen, or pelvis. The goal was to see if the improved images cou…
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC